Bayer Might Still Face Suit From Taiwan Patients Over Alleged HIV-tainted Blood Products
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - Taiwan plaintiffs are appealing a U.S. federal court ruling that they should file a suit that revolves around their infection from alleged HIV-tainted blood products sold by a Bayer affiliate back in Taiwan rather than in the United States